2021 Consultation Responses

The Royal Pharmaceutical Society responded to the following consultations in 2021.

December 2021

RPS response to consultation for original pack dispensing and supply of medicines containing sodium valproate | DHSC

RPS response to Review of temporary provisions in the Human Medicines Regulations 2012 to support influenza and Covid-19 vaccination campaigns | DHSC

Survey completed in response to the proposed Assisted Dying for Terminally Ill Adults (Scotland) Bill

Scottish Government consultation on Suicide Prevention Strategy Development

RPS response to consultation on Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults | NICE

Amending the Road Traffic Act 1988 to allow registered healthcare professionals to complete DVLA medical questionnaires I DVLA    


November 2021


RPS response to GPhC Consultation on changes to requirements for training as a pharmacist independent prescriber

Consultation on a National Care Service for Scotland and associated position statement | Scottish Government

RPS response to consultation on Extending free PPE to the health and care sector 

RPS response to survey on CORE20PLUS5 approach to reducing health inequalities |  NHSE/I


October 2021


Covid recovery: public health, services and justice system reforms

NICE Mental Wellbeing at Work Consultation Response | Institute for Apprenticeships and Technical Education

Response to T level outline consultation: Pharmacy Services Specialism | NICE

Royal Pharmaceutical Society response to the consultation on making vaccination a condition of deployment in the health and wider social care sector | DHSC


September 2021

Joint CPA & RPS Consultation Response Health Education England Global Strategy Refresh 2022-2025 | HEE

Consultation Response to Adult Support & Protection for GP's & Primary Care Teams | Scottish Government

Consultation Response from RPS Wales to HEIW Medicines Administration Units | HEIW Wales

Comment on All Wales Chronic Pain Resources  | AWTTC NHS Wales

RPS response to MHRA Point of Care Manufacture Consultation | MHRA

RPS response to consultation on Expanding access to Naloxone | DHSC

NHS 24 Strategic Planning Survey | Scotland


August 2021

Response to Collective Force for Health and Wellbeing Consultation: Refreshed action plan | COSLA

All Wales COPD Management and Prescribing Guideline | AWTTC NHS Wales

All Adult Wales Asthma Management and Prescribing Guideline��| AWTTC NHS Wales

Scottish Government Digital Health and Care website development survey | DHC Scotland

Consultation on Aligning prescription charges with the State Pension Age | DHSC England


July 2021

Consultation on the equality, diversity and inclusion strategy | GPhC

Race Equality Action Plan: An Anti-racist Wales | Welsh Gov

NHSX Data Strategy Survey | NHSX

Single Medication Record Survey | NHS Scotland


June 2021

Consultation on how we set fees for pharmacy professionals | GPhC

Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) consultation | MHRA

Regulating healthcare professionals, protecting the public | DHSC

Women's Health Strategy: Call for Evidence | DHSC

Review of Tramadol Resources | AWTTC


May 2021

Private coronavirus (COVID 19) testing validation | DHSC

Type 1 diabetes in adults: diagnosis and management (update) | NICE

Indicators for antidepressant prescribing and dementia | NICE

Consultation on a Patient Safety Commissioner Role for Scotland | Scottish Government

National Healthcare Uniform Workforce Consultation | NHS Supply Chain

Prescription medicine dependence and withdrawal | Scottish Government


April 2021

Draft Environmental Protection (single use plastic products) regulations | Scottish Government

Reviewing our process for health technology evaluation | NICE

Guideline on weight management | NICE

Call for Evidence – Barriers to research for controlled drugs (excluding synthetic cannabinoids) | ACMD


March 2021

Hana 75 microgram film-coated tablets (Desogestrel): Public Consultation | MHRA

Lovima 75 microgram film-coated tablets (Desogestrel): Public Consultation | MHRA

Strategy Consultation | CQC

Community Diagnostics | Welsh Government

Draft design principles – clinical and care professional leadership in Integrated Care Systems (ICSs) | NHS Confederation

Inquiry into the Covid-19 outbreak on health and social care in Wales: Post-Covid Syndrome | Welsh Parliament Health, Social Care and Sport Committee

White Paper on health and social care | House of Commons Health and Social Care Committee Department

NHS Provider Selection regime: Consultation on proposals | NHS


February 2021

Shared Decision Making | NICE

Transformation of Urgent and Emergency Care | NHS

Clostridioides difficile infection: antimicrobial prescribing - guideline consultation | NICE

Initial Clinical Management of Adult Smokers in Secondary Care | AWTTC

Guidance for the Provision of Anaesthetic Services for the Perioperative Care of Elective and Urgent Care Patients Consultation | RCoA

Termination of Pregnancy arrangements in Wales | Welsh Government

Home use of both pills for early medical abortion | DHSC


January 2021

Consultation on Future Arrangements for Early Medical Abortion at Home | Scottish Government

Workplace health: long-term sickness absence and capability to work | NICE

Your views: building a strong, integrated care system across England | NHS England

Managing concerns about pharmacy professionals: Our strategy for change | GPhC